Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT06238622




Registration number
NCT06238622
Ethics application status
Date submitted
25/01/2024
Date registered
2/02/2024
Date last updated
1/11/2024

Titles & IDs
Public title
A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550
Scientific title
An Open-label Extension Trial of the Long-term Safety and Efficacy of BI 1015550 Taken Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) (FIBRONEERâ„¢-ON)
Secondary ID [1] 0 0
2023-507353-15-00
Secondary ID [2] 0 0
1305-0031
Universal Trial Number (UTN)
Trial acronym
FIBRONEERâ„¢-ON
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Idiopathic Pulmonary Fibrosis 0 0
Progressive Pulmonary Fibrosis 0 0
Condition category
Condition code
Respiratory 0 0 0 0
Other respiratory disorders / diseases
Inflammatory and Immune System 0 0 0 0
Connective tissue diseases
Inflammatory and Immune System 0 0 0 0
Other inflammatory or immune system disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - BI 1015550

Experimental: BI 1015550 treatment group -


Treatment: Drugs: BI 1015550
BI 1015550

Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Occurrence of any adverse event over the course of the extension trial (yes/no)
Timepoint [1] 0 0
Up to 99 weeks and 3 days
Secondary outcome [1] 0 0
Absolute change from baseline in Forced vital capacity (FVC) (mL) over time
Timepoint [1] 0 0
Up to 98 weeks
Secondary outcome [2] 0 0
Absolute change from baseline in % predicted in Forced vital capacity (FVC) over time
Timepoint [2] 0 0
Up to 98 weeks
Secondary outcome [3] 0 0
Time to absolute decline in FVC % predicted of >10% from baseline over the duration of the trial
Timepoint [3] 0 0
Up to 98 weeks
Secondary outcome [4] 0 0
Time to first acute Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis (IPF/PPF) exacerbation, first hospitalisation for respiratory cause, or death (whichever occurs first) over the duration of the trial
Timepoint [4] 0 0
Up to 98 weeks
Secondary outcome [5] 0 0
Time to first acute Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis (IPF/PPF) exacerbation or death over the duration of the trial
Timepoint [5] 0 0
Up to 98 weeks
Secondary outcome [6] 0 0
Time to hospitalisation for respiratory cause or death over the duration of the trial
Timepoint [6] 0 0
Up to 98 weeks
Secondary outcome [7] 0 0
Time to absolute decline in Forced vital capacity (FVC) % predicted of >10% from baseline or death over the duration of the trial
Timepoint [7] 0 0
Up to 98 weeks
Secondary outcome [8] 0 0
Time to relative decline in Forced vital capacity (FVC) % predicted of >10% from baseline or death over the duration of the trial
Timepoint [8] 0 0
Up to 98 weeks

Eligibility
Key inclusion criteria
1. Patients who completed treatment in the parent trials (1305-0014 or 1305-0023) without prematurely discontinuing treatment permanently according to protocol (i.e. completed treatment with or without temporary treatment interruption)
2. Signed and dated written informed consent in accordance with ICH-GCP and local legislation prior to admission to the trial
3. Women of childbearing potential (WOCBP) must be ready and able to use highly effective methods of birth control per ICH M3 (R2) that result in a low failure rate of less than 1% per year when used consistently and correctly. WOCBP taking oral contraceptives (OCs) also have to ensure the use of one barrier method during sexual intercourse with their partner, e.g., condom to account for the risk of potentially reduced efficacy of the OCs in the event of severe vomiting and diarrhoea. For France, fertile males must be ready and able to use acceptable methods of birth control
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Any disease that may put the patient at risk when participating in this trial at investigator's discretion.
2. Patient exhibits suicidality, in the clinical judgment of the investigator or according to the following criteria at Visit 1:

* any suicidal behaviour (i.e. actual attempt, interrupted attempt, aborted attempt, or preparatory acts or behaviour)
* any suicidal ideation of type 4 or 5 in the Columbia-Suicide Severity Rating Scale (C-SSRS) (i.e. active suicidal thought with intent but without specific plan, or active suicidal thought with plan and intent)
3. Patients with clinically relevant severe depression at investigator's discretion or a Hospital Anxiety and Depression Scale (HADS) subscore >14 at Visit 1.
4. An occurrence of malignant neoplasm other than appropriately treated basal cell carcinoma or in situ squamous cell carcinoma of the skin or in situ carcinoma of uterine cervix at Visit 1.
5. Patient will undergo lung transplantation, with an assigned date of surgery.
6. Patients with a Body Mass index (BMI) <18.5 kg/m² that experienced an additional, unexplained and clinically significant (>10%) weight loss during the parent trial
7. At Visit 1, patients with ongoing Adverse Event of Special Interest (AESI) (suspected vasculitis, Drug Induced Liver Injury (DILI), severe infections) that led to temporary treatment interruption in the parent trial
8. Patients who must or wish to take restricted medications or any drug considered likely to interfere with the safe conduct of the trial.

Further exclusion criteria apply.

Study design
Purpose of the study
Treatment
Allocation to intervention
Not applicable
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW,QLD,VIC,WA
Recruitment hospital [1] 0 0
Canberra Hospital - Garran
Recruitment hospital [2] 0 0
Royal Prince Alfred Hospital - Camperdown
Recruitment hospital [3] 0 0
Lung Research Queensland - Chermside
Recruitment hospital [4] 0 0
The Prince Charles Hospital - Chermside
Recruitment hospital [5] 0 0
Austin Hospital - Heidelberg
Recruitment hospital [6] 0 0
The Alfred Hospital - Melbourne
Recruitment hospital [7] 0 0
Fiona Stanley Hospital - Murdoch
Recruitment hospital [8] 0 0
Trialswest - Spearwood
Recruitment postcode(s) [1] 0 0
2605 - Garran
Recruitment postcode(s) [2] 0 0
2050 - Camperdown
Recruitment postcode(s) [3] 0 0
4032 - Chermside
Recruitment postcode(s) [4] 0 0
3084 - Heidelberg
Recruitment postcode(s) [5] 0 0
3004 - Melbourne
Recruitment postcode(s) [6] 0 0
6150 - Murdoch
Recruitment postcode(s) [7] 0 0
6153 - Spearwood
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
California
Country [2] 0 0
United States of America
State/province [2] 0 0
Colorado
Country [3] 0 0
United States of America
State/province [3] 0 0
Connecticut
Country [4] 0 0
United States of America
State/province [4] 0 0
Delaware
Country [5] 0 0
United States of America
State/province [5] 0 0
Florida
Country [6] 0 0
United States of America
State/province [6] 0 0
Georgia
Country [7] 0 0
United States of America
State/province [7] 0 0
Illinois
Country [8] 0 0
United States of America
State/province [8] 0 0
Kansas
Country [9] 0 0
United States of America
State/province [9] 0 0
Louisiana
Country [10] 0 0
United States of America
State/province [10] 0 0
Massachusetts
Country [11] 0 0
United States of America
State/province [11] 0 0
Michigan
Country [12] 0 0
United States of America
State/province [12] 0 0
Minnesota
Country [13] 0 0
United States of America
State/province [13] 0 0
Missouri
Country [14] 0 0
United States of America
State/province [14] 0 0
Nebraska
Country [15] 0 0
United States of America
State/province [15] 0 0
Nevada
Country [16] 0 0
United States of America
State/province [16] 0 0
New Hampshire
Country [17] 0 0
United States of America
State/province [17] 0 0
New York
Country [18] 0 0
United States of America
State/province [18] 0 0
North Carolina
Country [19] 0 0
United States of America
State/province [19] 0 0
Ohio
Country [20] 0 0
United States of America
State/province [20] 0 0
Oregon
Country [21] 0 0
United States of America
State/province [21] 0 0
Pennsylvania
Country [22] 0 0
United States of America
State/province [22] 0 0
South Carolina
Country [23] 0 0
United States of America
State/province [23] 0 0
Tennessee
Country [24] 0 0
United States of America
State/province [24] 0 0
Washington
Country [25] 0 0
United States of America
State/province [25] 0 0
Wisconsin
Country [26] 0 0
Argentina
State/province [26] 0 0
C.a.b.a
Country [27] 0 0
Argentina
State/province [27] 0 0
Caba
Country [28] 0 0
Argentina
State/province [28] 0 0
Capital Federal
Country [29] 0 0
Argentina
State/province [29] 0 0
Mendoza
Country [30] 0 0
Austria
State/province [30] 0 0
Krems
Country [31] 0 0
Austria
State/province [31] 0 0
Salzburg
Country [32] 0 0
Austria
State/province [32] 0 0
Vienna
Country [33] 0 0
Austria
State/province [33] 0 0
Wels
Country [34] 0 0
Belgium
State/province [34] 0 0
Antwerpen
Country [35] 0 0
Belgium
State/province [35] 0 0
Bruxelles
Country [36] 0 0
Belgium
State/province [36] 0 0
Leuven
Country [37] 0 0
Belgium
State/province [37] 0 0
Yvoir
Country [38] 0 0
Brazil
State/province [38] 0 0
Belo Horizonte,Minas Gerais
Country [39] 0 0
Brazil
State/province [39] 0 0
Curitiba
Country [40] 0 0
Brazil
State/province [40] 0 0
Goiania
Country [41] 0 0
Brazil
State/province [41] 0 0
Porto Alegre
Country [42] 0 0
Brazil
State/province [42] 0 0
Sao Paulo
Country [43] 0 0
Brazil
State/province [43] 0 0
São Bernardo do Campo
Country [44] 0 0
Canada
State/province [44] 0 0
Alberta
Country [45] 0 0
Canada
State/province [45] 0 0
British Columbia
Country [46] 0 0
Canada
State/province [46] 0 0
New Brunswick
Country [47] 0 0
Canada
State/province [47] 0 0
Nova Scotia
Country [48] 0 0
Canada
State/province [48] 0 0
Ontario
Country [49] 0 0
Canada
State/province [49] 0 0
Quebec
Country [50] 0 0
Chile
State/province [50] 0 0
Providencia, Santiago De Chile
Country [51] 0 0
Chile
State/province [51] 0 0
Talca
Country [52] 0 0
China
State/province [52] 0 0
Beijing
Country [53] 0 0
China
State/province [53] 0 0
Changsha
Country [54] 0 0
China
State/province [54] 0 0
Chengdu
Country [55] 0 0
China
State/province [55] 0 0
Guangzhou
Country [56] 0 0
China
State/province [56] 0 0
Hangzhou
Country [57] 0 0
China
State/province [57] 0 0
Hefei
Country [58] 0 0
China
State/province [58] 0 0
Jiaxing
Country [59] 0 0
China
State/province [59] 0 0
Nanjing
Country [60] 0 0
China
State/province [60] 0 0
Ningbo
Country [61] 0 0
China
State/province [61] 0 0
Shanghai
Country [62] 0 0
China
State/province [62] 0 0
Shenyang
Country [63] 0 0
China
State/province [63] 0 0
Shenzhen
Country [64] 0 0
China
State/province [64] 0 0
Suzhou
Country [65] 0 0
China
State/province [65] 0 0
Tianjin
Country [66] 0 0
China
State/province [66] 0 0
Wuhan
Country [67] 0 0
China
State/province [67] 0 0
Wuxi
Country [68] 0 0
China
State/province [68] 0 0
Xuzhou
Country [69] 0 0
China
State/province [69] 0 0
Yichang
Country [70] 0 0
Denmark
State/province [70] 0 0
Hellerup
Country [71] 0 0
Denmark
State/province [71] 0 0
Odense C
Country [72] 0 0
Estonia
State/province [72] 0 0
Tallinn
Country [73] 0 0
Finland
State/province [73] 0 0
Helsinki
Country [74] 0 0
Finland
State/province [74] 0 0
Oulu
Country [75] 0 0
France
State/province [75] 0 0
Angers
Country [76] 0 0
France
State/province [76] 0 0
Bobigny
Country [77] 0 0
France
State/province [77] 0 0
Brest
Country [78] 0 0
France
State/province [78] 0 0
Bron
Country [79] 0 0
France
State/province [79] 0 0
Caen
Country [80] 0 0
France
State/province [80] 0 0
Dijon
Country [81] 0 0
France
State/province [81] 0 0
La Tronche
Country [82] 0 0
France
State/province [82] 0 0
Le Kremlin-Bicêtre
Country [83] 0 0
France
State/province [83] 0 0
Lille
Country [84] 0 0
France
State/province [84] 0 0
Marseille
Country [85] 0 0
France
State/province [85] 0 0
Nantes
Country [86] 0 0
France
State/province [86] 0 0
Nice
Country [87] 0 0
France
State/province [87] 0 0
Paris
Country [88] 0 0
France
State/province [88] 0 0
Pessac
Country [89] 0 0
France
State/province [89] 0 0
Reims
Country [90] 0 0
France
State/province [90] 0 0
Rennes
Country [91] 0 0
France
State/province [91] 0 0
Rouen
Country [92] 0 0
France
State/province [92] 0 0
Suresnes
Country [93] 0 0
France
State/province [93] 0 0
Toulouse
Country [94] 0 0
Germany
State/province [94] 0 0
Ahrensburg
Country [95] 0 0
Germany
State/province [95] 0 0
Bamberg
Country [96] 0 0
Germany
State/province [96] 0 0
Bonn
Country [97] 0 0
Germany
State/province [97] 0 0
Coswig
Country [98] 0 0
Germany
State/province [98] 0 0
Essen
Country [99] 0 0
Germany
State/province [99] 0 0
Hamburg
Country [100] 0 0
Germany
State/province [100] 0 0
Hannover
Country [101] 0 0
Germany
State/province [101] 0 0
Heidelberg
Country [102] 0 0
Germany
State/province [102] 0 0
Hemer
Country [103] 0 0
Germany
State/province [103] 0 0
Immenhausen
Country [104] 0 0
Germany
State/province [104] 0 0
Konstanz
Country [105] 0 0
Germany
State/province [105] 0 0
München
Country [106] 0 0
Germany
State/province [106] 0 0
Solingen
Country [107] 0 0
Germany
State/province [107] 0 0
Stralsund
Country [108] 0 0
Germany
State/province [108] 0 0
Stuttgart
Country [109] 0 0
Germany
State/province [109] 0 0
Tübingen
Country [110] 0 0
Greece
State/province [110] 0 0
Heraclion
Country [111] 0 0
Greece
State/province [111] 0 0
Patras
Country [112] 0 0
Hungary
State/province [112] 0 0
Budapest
Country [113] 0 0
Hungary
State/province [113] 0 0
Debrecen
Country [114] 0 0
Italy
State/province [114] 0 0
Catania
Country [115] 0 0
Italy
State/province [115] 0 0
Firenze
Country [116] 0 0
Italy
State/province [116] 0 0
Foggia
Country [117] 0 0
Italy
State/province [117] 0 0
Forli'
Country [118] 0 0
Italy
State/province [118] 0 0
Milano
Country [119] 0 0
Italy
State/province [119] 0 0
Padova
Country [120] 0 0
Italy
State/province [120] 0 0
Roma
Country [121] 0 0
Italy
State/province [121] 0 0
Siena
Country [122] 0 0
Italy
State/province [122] 0 0
Torrette Di Ancona (Ancona)
Country [123] 0 0
Japan
State/province [123] 0 0
Aichi, Seto
Country [124] 0 0
Japan
State/province [124] 0 0
Chiba, Chiba
Country [125] 0 0
Japan
State/province [125] 0 0
Fukui, Yoshida-gun
Country [126] 0 0
Japan
State/province [126] 0 0
Fukuoka, Fukuoka
Country [127] 0 0
Japan
State/province [127] 0 0
Fukuoka, Kurume
Country [128] 0 0
Japan
State/province [128] 0 0
Fukushima, Koriyama
Country [129] 0 0
Japan
State/province [129] 0 0
Hiroshima, Hiroshima
Country [130] 0 0
Japan
State/province [130] 0 0
Hokkaido, Sapporo
Country [131] 0 0
Japan
State/province [131] 0 0
Hyogo, Himeji
Country [132] 0 0
Japan
State/province [132] 0 0
Hyogo, Kobe
Country [133] 0 0
Japan
State/province [133] 0 0
Kanagawa, Yokohama
Country [134] 0 0
Japan
State/province [134] 0 0
Kumamoto, Kumamoto
Country [135] 0 0
Japan
State/province [135] 0 0
Nagasaki, Nagasaki
Country [136] 0 0
Japan
State/province [136] 0 0
Osaka, Osakasayama
Country [137] 0 0
Japan
State/province [137] 0 0
Osaka, Sakai
Country [138] 0 0
Japan
State/province [138] 0 0
Shimane, Izumo
Country [139] 0 0
Japan
State/province [139] 0 0
Shizuoka, Hamamatsu
Country [140] 0 0
Japan
State/province [140] 0 0
Tochigi, Shimotsuke
Country [141] 0 0
Japan
State/province [141] 0 0
Tokushima, Tokushima
Country [142] 0 0
Japan
State/province [142] 0 0
Tokyo, Bunkyo-ku
Country [143] 0 0
Japan
State/province [143] 0 0
Tokyo, Minato-ku
Country [144] 0 0
Japan
State/province [144] 0 0
Tokyo, Mitaka
Country [145] 0 0
Japan
State/province [145] 0 0
Tokyo, Ota-ku
Country [146] 0 0
Japan
State/province [146] 0 0
Tokyo, Shinjuku-ku
Country [147] 0 0
Japan
State/province [147] 0 0
Wakayama, Wakayama
Country [148] 0 0
Korea, Republic of
State/province [148] 0 0
Bucheon
Country [149] 0 0
Korea, Republic of
State/province [149] 0 0
Seongnam
Country [150] 0 0
Korea, Republic of
State/province [150] 0 0
Seoul
Country [151] 0 0
Malaysia
State/province [151] 0 0
George Town
Country [152] 0 0
Malaysia
State/province [152] 0 0
Kajang
Country [153] 0 0
Malaysia
State/province [153] 0 0
Kuala Lumpur
Country [154] 0 0
Mexico
State/province [154] 0 0
Chihuahua
Country [155] 0 0
Mexico
State/province [155] 0 0
Monterrey
Country [156] 0 0
Netherlands
State/province [156] 0 0
HEERLENHeerlen
Country [157] 0 0
Netherlands
State/province [157] 0 0
Nieuwegein
Country [158] 0 0
Netherlands
State/province [158] 0 0
Rotterdam
Country [159] 0 0
New Zealand
State/province [159] 0 0
Hamilton
Country [160] 0 0
New Zealand
State/province [160] 0 0
One Tree Hill, Auckland
Country [161] 0 0
New Zealand
State/province [161] 0 0
Tauranga South
Country [162] 0 0
Norway
State/province [162] 0 0
Bergen
Country [163] 0 0
Norway
State/province [163] 0 0
Nordbyhagen
Country [164] 0 0
Norway
State/province [164] 0 0
Oslo
Country [165] 0 0
Poland
State/province [165] 0 0
Gdansk
Country [166] 0 0
Poland
State/province [166] 0 0
Warsaw
Country [167] 0 0
Portugal
State/province [167] 0 0
Coimbra
Country [168] 0 0
Portugal
State/province [168] 0 0
Matosinhos
Country [169] 0 0
Singapore
State/province [169] 0 0
Singapore
Country [170] 0 0
South Africa
State/province [170] 0 0
Durban
Country [171] 0 0
Spain
State/province [171] 0 0
Alicante
Country [172] 0 0
Spain
State/province [172] 0 0
Barcelona
Country [173] 0 0
Spain
State/province [173] 0 0
Bilbao
Country [174] 0 0
Spain
State/province [174] 0 0
Galdakao
Country [175] 0 0
Spain
State/province [175] 0 0
Granada
Country [176] 0 0
Spain
State/province [176] 0 0
L'Hospitalet de Llobregat
Country [177] 0 0
Spain
State/province [177] 0 0
Madrid
Country [178] 0 0
Spain
State/province [178] 0 0
Malaga
Country [179] 0 0
Spain
State/province [179] 0 0
Oviedo
Country [180] 0 0
Spain
State/province [180] 0 0
Palma de Mallorca
Country [181] 0 0
Spain
State/province [181] 0 0
Pozuelo de Alarcón
Country [182] 0 0
Spain
State/province [182] 0 0
Santander
Country [183] 0 0
Spain
State/province [183] 0 0
Santiago de Compostela
Country [184] 0 0
Spain
State/province [184] 0 0
Sevilla
Country [185] 0 0
Spain
State/province [185] 0 0
Valencia
Country [186] 0 0
Sweden
State/province [186] 0 0
Linköping
Country [187] 0 0
Sweden
State/province [187] 0 0
Uppsala
Country [188] 0 0
Switzerland
State/province [188] 0 0
Basel
Country [189] 0 0
Taiwan
State/province [189] 0 0
Changhua
Country [190] 0 0
Taiwan
State/province [190] 0 0
Kaohsiung
Country [191] 0 0
Taiwan
State/province [191] 0 0
Taichung
Country [192] 0 0
Taiwan
State/province [192] 0 0
Tainan
Country [193] 0 0
Taiwan
State/province [193] 0 0
Taipei
Country [194] 0 0
Thailand
State/province [194] 0 0
Bangkok Noi
Country [195] 0 0
Thailand
State/province [195] 0 0
Khon Kaen
Country [196] 0 0
Thailand
State/province [196] 0 0
Ratchatewi
Country [197] 0 0
Thailand
State/province [197] 0 0
Songkhla
Country [198] 0 0
United Kingdom
State/province [198] 0 0
Bristol
Country [199] 0 0
United Kingdom
State/province [199] 0 0
Exeter
Country [200] 0 0
United Kingdom
State/province [200] 0 0
Lancaster
Country [201] 0 0
United Kingdom
State/province [201] 0 0
London
Country [202] 0 0
United Kingdom
State/province [202] 0 0
Manchester

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Boehringer Ingelheim
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medicine called BI 1015550 (study 1305-0014 or 1305-0023).

The goal of this study is to find out how well people with pulmonary fibrosis tolerate longterm treatment with BI 1015550. The study also tests whether BI 1015550 improves lung function and prolongs the time until symptoms get worse, participants need to go to the hospital, or die.

Every participant takes BI 1015550 as tablets for up to 1 year and 10 months. The participants may also continue their regular treatment for pulmonary fibrosis during the study.

Participants visit their doctors regularly. During these visits, the doctors collect information on any health problems of the participants. Participants also regularly do lung function tests.
Trial website
https://clinicaltrials.gov/study/NCT06238622
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Boehringer Ingelheim
Address 0 0
Country 0 0
Phone 0 0
1-800-243-0127
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT06238622